Canada
· Delayed Price · Currency is CAD Voyageur Pharmaceuticals Statistics
Total Valuation
Voyageur Pharmaceuticals has a market cap or net worth of CAD 22.32 million. The enterprise value is 22.35 million.
| Market Cap | 22.32M |
| Enterprise Value | 22.35M |
Important Dates
The next estimated earnings date is Monday, March 24, 2025.
| Earnings Date | Mar 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Voyageur Pharmaceuticals has 139.47 million shares outstanding. The number of shares has increased by 8.55% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 139.47M |
| Shares Change (YoY) | +8.55% |
| Shares Change (QoQ) | +0.41% |
| Owned by Insiders (%) | 10.29% |
| Owned by Institutions (%) | n/a |
| Float | 125.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 23.62 |
| P/TBV Ratio | 23.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -14.60 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -44.58 |
Financial Position
The company has a current ratio of 0.10, with a Debt / Equity ratio of 0.04.
| Current Ratio | 0.10 |
| Quick Ratio | 0.03 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.08 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -115.50% and return on invested capital (ROIC) is -61.53%.
| Return on Equity (ROE) | -115.50% |
| Return on Assets (ROA) | -37.08% |
| Return on Capital (ROIC) | -61.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +68.75% in the last 52 weeks. The beta is 0.14, so Voyageur Pharmaceuticals's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | +68.75% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.07 |
| Relative Strength Index (RSI) | 70.04 |
| Average Volume (20 Days) | 359,672 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.34M |
| Pretax Income | -1.53M |
| Net Income | -1.53M |
| EBITDA | -1.34M |
| EBIT | -1.34M |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 6,535 in cash and 40,000 in debt, giving a net cash position of -33,465 or -0.00 per share.
| Cash & Cash Equivalents | 6,535 |
| Total Debt | 40,000 |
| Net Cash | -33,465 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 944,818 |
| Book Value Per Share | 0.01 |
| Working Capital | -1.21M |
Cash Flow
In the last 12 months, operating cash flow was -337,520 and capital expenditures -163,840, giving a free cash flow of -501,360.
| Operating Cash Flow | -337,520 |
| Capital Expenditures | -163,840 |
| Free Cash Flow | -501,360 |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Voyageur Pharmaceuticals does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.55% |
| Shareholder Yield | -8.55% |
| Earnings Yield | -7.04% |
| FCF Yield | -2.25% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |